Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

59 results
Display

Characteristics and Clinical Outcomes of Extended-Spectrum beta-lactamaseproducing Klebsiella pneumoniae Bacteremia in Cancer Patients

Nham E, Huh K, Cho SY, Chung DR, Peck KR, Lee NY, Kang CI

Background: Cancer patients can be at a higher risk of infection due to drug-resistant bacteria than the general population for various reasons. We performed a retrospective study to evaluate possible...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Prediction Score for Community-Onset Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella Species

Kim M, Song KH, Kim CJ, Choe PG, Park WB, Bang JH, Kim ES, Park SW, Kim NJ, Oh MD, Kim HB

BACKGROUND: This study aimed to identify the predictors and build a prediction score for community-onset bloodstream infections (CO-BSIs) caused by extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella species. METHODS: All CO-BSIs...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase Escherichia coli and Klebsiella species

Koksal E, Tulek N, Sonmezer M, Temocin F, Bulut C, Hatipoglu , Erdinc FS, Ertem G

PURPOSE: The aim of this study was to determine the prevalence and risk factors for community-acquired urinary tract infections (CA-UTIs) caused by extended-spectrum β-lactamase (ESBL) producing Escherichia coli and Klebsiella...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Failure of Ciprofloxacin Therapy in the Treatment of Community-Acquired Acute Pyelonephritis caused by In-Vitro Susceptible Escherichia coli Strain Producing CTX-Type Extended-Spectrum β-Lactamase

Seok H, Cha MK, Kang CI, Cho SY, Kim SH, Ha YE, Chung DR, Peck KR, Song JH

While carbapenems are the drug of choice to treat extended-spectrum-β-lactamase (ESBL)-producing strains, some alternative carbapenem-sparing regimens are suggested for antibiotic stewardship. We experienced a case of ciprofloxacin treatment failure for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Use of Non-carbapenem Antibiotics in Patients with Urinary Tract Infection Caused by Extended-spectrum Beta-lactamase-producing Enterobacteriaceae

Seo YB, Kim YK, Lee J, Song W

BACKGROUND: Alternatives to carbapenem are increasingly needed to decrease the usage of carbapenem. We evaluated the possibility of using non-carbapenem antibiotics against urinary tract infections (UTI) caused by extended-spectrum beta-lactamase-producing...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea

Lee Y, Lee DG, Lee SH, Yoo KH

The objectives of this study were to investigate risk factors and the incidence of ciprofloxacin resistance and extended-spectrum beta-lactamases (ESBL) in patients with acute bacterial prostatitis (ABP). We reviewed the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Febrile Urinary Tract Infections Caused by Community-Acquired Extended-Spectrum beta-Lactamase-Producing and-Nonproducing Bacteria: A Comparative Study

Ahn DH, Kim KW, Cho HK, Tchah H, Jeon IS, Ryoo E, Sun YH

PURPOSE: The purpose of this study was to investigate the clinical characteristics and outcome of febrile urinary tract infections (UTIs) caused by community-acquired extended-spectrum beta-lactamase (CA-ESBL)-producing and -nonproducing bacteria. METHODS: We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of Extended-Spectrum Beta-Lactamase-Positive Gram-Negative Bacterial Urologic Infections

Lim YK, Lee MK, Kim TH

Extended-spectrum beta-lactamases (ESBLs) are enzymes that confer increased resistance to commonly used antibiotics. The prevalence rates of ESBL producing bacteria are increasing, and the associated increase in morbidity and mortality...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Antibiotic Resistance Pattern of Gram-Negative Bacteria in Children Younger Than 24 Months with a Urinary Tract Infection: A Retrospective Single-Center Study over 15 Consecutive Years

Lee YK, Lee H, Kim JM, Kang JM, Lee ST, Lee NY, Kim YJ, Cho H

PURPOSE: We investigated trends in antibiotic resistance for gram-negative bacteria in infants with a urinary tract infection (UTI) over 15 years at a single institution. METHODS: A retrospective chart review was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Characterization of Salmonella spp. Clinical Isolates in Gyeongsangbuk-do Province, 2012 to 2013

Kweon OG, Kim JS, Kim GO, Lee CI, Jeong KH, Kim J

BACKGROUND: Extended-spectrum cephalosporins and fluoroquinolones are important antimicrobials for treating invasive salmonellosis, and emerging resistance to these antimicrobials is of paramount concern. METHODS: A total of 30 Salmonella spp. clinical isolates...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Native valve endocarditis due to extended spectrum beta-lactamase producing Klebsiella pneumoniae

Jung HA, Ha YE, Kim D, Park J, Kang CI, Chung DR, Park SW, Sung KI, Song JH, Peck KR

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Strategies for Interpretive Standards of beta-Lactams Susceptibility Testing and Identification of Extended-Spectrum beta-Lactamases and Carbapenemases in Enterobacteriaceae

Park YJ, Song W

The Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) have recently revised the susceptibility interpretive criteria of oxyimino-beta-lactams and carbapenems for Enterobacteriaceae. According...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Higher Prevalence of Klebsiella pneumoniae Extended-Spectrum beta-Lactamase in Patients on Renal Replacement Therapy

Lee HL, Whang DH, Park DW, Lee YJ, Kim YH, Chin HJ, Kim S, Koo HS

The prevalence of antibiotic resistance is higher in patients undergoing renal replacement therapy (RRT) than in patients who did not undergo RRT. We investigated the presence of KP (Klebsiella pneumoniae)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk Factors of Nosocomial Bacteremia of Extended-spectrum beta-Lactamase Producing Escherichia coli

Ko D, Moon SM, Lee JS, Park YS, Cho YK

  • KMID: 2320018
  • Yeungnam Univ J Med.
  • 2013 Dec;30(2):83-89.
BACKGROUND: The prevalence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli is increasing rapidly worldwide. Treatment options for ESBL-producing E. coli are limited, and infections caused by this organism are associated with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Outcome of Antimicrobial Therapy of Pediatric Urinary Tract Infections Caused by Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae

Lee B, Kang SY, Kang HM, Yang NR, Kang HG, Ha IS, Cheong HI, Lee HJ, Choi EH

BACKGROUND: The purpose of this study was to compare the outcome of carbapenem versus non-carbapenem antimicrobial therapy for pediatric urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae. MATERIALS...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Significance of Extended-Spectrum beta-Lactamase Producing Escherichia coli in Pediatric Patients with Febrile Urinary Tract Infection

Park C, Kim MS, Kim MK, Yim HE, Yoo KH, Hong YS, Lee JW

  • KMID: 2144670
  • J Korean Soc Pediatr Nephrol.
  • 2012 Apr;16(1):38-45.
PURPOSE: The incidence of community-acquired urinary tract infection (UTI) due to extended-spectrum beta-lactamase producing Escherichia coli (ESBL(+) E. coli) has increased worldwide. ESBL causes resistance to various types of the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Korean Nationwide Surveillance Study for Non-Typhoidal Salmonella Isolated in Humans and Food Animals from 2006 to 2008: Extended-Spectrum beta-Lactamase, Plasmid-Mediated AmpC beta-Lactamase, and Plasmid-Mediated Quinolone Resistance qnr Genes

Chung HS, Lee H, Lee Y, Yong D, Jeong SH, Lee BK, Jung SC, Lim SK, Lee K, Chong Y

BACKGROUND: The emergence of non-typhoidal Salmonella (NTS) with decreased susceptibilities to fluoroquinolone, ampicillin, or ceftriaxone has been reported worldwide. However, current surveillance studies of resistance among NTS in Korea are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of MicroScan and Phoenix Automated Systems for Detection of Extended-Spectrum beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae

Jin WY, Jang SJ, Kim YS, Park G, Moon DS, Park YJ

The aim of this study was to evaluate the performances of MicroScan (Siemens Healthcare, USA) and Phoenix (Becton Dickinson Diagnostic Systems, USA) automated systems for the detection of extended-spectrum beta-lactamase...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence of Extended-spectrum beta-lactamase among Enterobacteriacae Blood Isolates with Inducible AmpC beta-lactamase

Cheong HS, Ko KS, Kang CI, Chung DR, Peck KR, Song JH

BACKGROUND: Among the inducible AmpC beta-lactamase-producing members of the family Enterobacteriaceae such as Enterobacter spp., Citrobacter spp., Serratia spp., and Morganella morganii (ECSM), the prevalence of ESBL-producing isolates are increasing....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Use of Boronic Acid Disks for the Detection of Extended-spectrum beta-lactamase and AmpC beta-lactamase in Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca and Proteus mirabilis

Park SD, Uh Y, Jang IH, Kwon O, Yoon KJ, Kim HY

BACKGROUND: Accurate detection of organisms producing extended-spectrum beta-lactamase (ESBL) and AmpC beta-lactamase is very important for treatment of patients. However, unlike the ESBL confirmatory test, there are no guidelines for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr